GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hualan Biological Engineering Inc (SZSE:002007) » Definitions » EV-to-FCF

Hualan Biological Engineering (SZSE:002007) EV-to-FCF : 67.45 (As of Dec. 11, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Hualan Biological Engineering EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Hualan Biological Engineering's Enterprise Value is ¥29,410 Mil. Hualan Biological Engineering's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was ¥436 Mil. Therefore, Hualan Biological Engineering's EV-to-FCF for today is 67.45.

The historical rank and industry rank for Hualan Biological Engineering's EV-to-FCF or its related term are showing as below:

SZSE:002007' s EV-to-FCF Range Over the Past 10 Years
Min: -6810.09   Med: 74.74   Max: 1266.39
Current: 66.65

During the past 13 years, the highest EV-to-FCF of Hualan Biological Engineering was 1266.39. The lowest was -6810.09. And the median was 74.74.

SZSE:002007's EV-to-FCF is ranked worse than
84.2% of 386 companies
in the Biotechnology industry
Industry Median: 8.605 vs SZSE:002007: 66.65

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2024-12-11), Hualan Biological Engineering's stock price is ¥17.19. Hualan Biological Engineering's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was ¥0.731. Therefore, Hualan Biological Engineering's PE Ratio (TTM) for today is 23.52.


Hualan Biological Engineering EV-to-FCF Historical Data

The historical data trend for Hualan Biological Engineering's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hualan Biological Engineering EV-to-FCF Chart

Hualan Biological Engineering Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 42.47 105.15 82.97 72.32 68.25

Hualan Biological Engineering Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 49.90 68.25 103.39 110.12 75.46

Competitive Comparison of Hualan Biological Engineering's EV-to-FCF

For the Biotechnology subindustry, Hualan Biological Engineering's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hualan Biological Engineering's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hualan Biological Engineering's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Hualan Biological Engineering's EV-to-FCF falls into.



Hualan Biological Engineering EV-to-FCF Calculation

Hualan Biological Engineering's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=29410.069/436.046
=67.45

Hualan Biological Engineering's current Enterprise Value is ¥29,410 Mil.
Hualan Biological Engineering's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥436 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hualan Biological Engineering  (SZSE:002007) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Hualan Biological Engineering's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=17.19/0.731
=23.52

Hualan Biological Engineering's share price for today is ¥17.19.
Hualan Biological Engineering's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.731.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Hualan Biological Engineering EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Hualan Biological Engineering's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Hualan Biological Engineering Business Description

Traded in Other Exchanges
N/A
Address
No. 1, Hualan Avenue, Henan Province, Xinxiang, CHN, 453003
Hualan Biological Engineering Inc is a China-based biopharmaceutical company. It is engaged in the research, development, production, and commercialization of plasma products, viral vaccines, bacterial vaccines, and recombinant proteins and other biologics. The plasma products offered by the company include Human albumin, Human fibrinogen, Human tetanus immunoglobulin and others. The vaccines products include Recombinant hepatitis B vaccine, Inactivated influenza vaccine and other. It also offers gene products such as Monoclonal Antibody for tumor, autoimmune diseases, infectious diseases, transplant rejection, and Recombinant monoclonal antibodies.
Executives
Chen Zheng Yue Executives
Fan Bei Directors, executives
Pan Ruo Wen Executives
Xie Jun Min Directors, executives
An Wen Qi Executives
An Kang Directors, executives
Ma Xiao Wei Executives
Zhang Bao Xian Executives
An Wen Jue Director
Liu Jun Executives
Wang Qi Ping Directors, executives
Lv Cheng Yu Securities Affairs Representative
Zhang Jin Gang Independent director
Wang Li Ting Independent director
Ma Li Supervisors

Hualan Biological Engineering Headlines

No Headlines